Position in QURE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,743,627
+$10,851,877 QoQ
Shares Held
450,361
-25.6% QoQ
Ownership
0.714%
of shares outstanding
% of Portfolio
1.04%
of 13F equity value
Holder Rank
#39
of 254 holders
Holding Since
Mar 2020
13 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in QURE Over Time
Shares Held
Position Value (USD)
Derivatives in QURE
reported options exposure · as of Mar 31, 2026CallValue
$817,500
CallShares
50,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Voss Capital, LP holds $29,284,427 across 5 Biotechnology names. QURE ranks #1 (70.8% of the industry book) .
All Filings in QURE
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,743,627 | 450,361 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $9,891,750 | 605,000 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $817,500 | 50,000 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $5,025,300 | 210,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,296,250 | 125,000 | Shares | Sole | 2025-11-20 | |
| 2025-06-30 | $1,742,500 | 125,000 | Shares | Sole | 2025-08-13 | |
| 2022-06-30 | $2,423,200 | 130,000 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,264,900 | 70,000 | Shares | Sole | 2022-05-13 | |
| 2021-06-30 | $1,244,412 | 40,403 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,032,099 | 90,000 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,348,450 | 65,000 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $3,748,041 | 101,766 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $3,154,200 | 70,000 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,262,875 | 127,500 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||